Copper Activation of NF-κB Signaling in HepG2 Cells

Journal of Molecular Biology

Volumn 393, Issue 5, 2009, Pages 1013-1021

  McElwee, Matthew K ^a,b   Song, Min Ok ^a   Freedman, Jonathan H ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

copper; gene expression; HepG2 cells; microarray; NF B

Indexed keywords

BETA ACTIN; COPPER; GLUTAMATE CYSTEINE LIGASE; HEAT SHOCK PROTEIN; HEME OXYGENASE 1; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LUCIFERASE; OXIDOREDUCTASE; SMALL INTERFERING RNA; SULFIREDOXIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ARTICLE; CELL STRAIN HEPG2; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ASSAY; GENE ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; COPPER; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; HYDROGEN PEROXIDE; I-KAPPA B KINASE; NF-KAPPA B; PROTEIN KINASE INHIBITORS; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

EID: 70350131071     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.08.077     Document Type: Article

References (47)

1. Olivares M., and Uauy R. Copper as an essential nutrient. Am. J. Clin. Nutr. 63 (1996) 791S-796S
2. Barceloux D.G. Copper. J. Toxicol. Clin. Toxicol. 37 (1999) 217-230
3. Madsen E., and Gitlin J.D. Copper deficiency. Curr. Opin. Gastroenterol. 23 (2007) 187-192
4. Keen C.L., Hanna L.A., Lanoue L., Uriu-Adams J.Y., Rucker R.B., and Clegg M.S. Developmental consequences of trace mineral deficiencies in rodents: acute and long-term effects. J. Nutr. 133 (2003) 1477S-1480S
5. Menkes J.H. Menkes disease and Wilson disease: two sides of the same copper coin. Part I: Menkes disease. Eur. J. Paediatr. Neurol. 3 (1999) 147-158
6. Menkes J.H. Menkes disease and Wilson disease: two sides of the same copper coin. Part II: Wilson disease. Eur. J. Paediatr. Neurol. 3 (1999) 245-253
7. Ferenci P. Wilson's disease. Clin. Gastroenterol. Hepatol. 3 (2005) 726-733
8. DiDonato M., and Sarkar B. Copper transport and its alterations in Menkes and Wilson diseases. Biochim. Biophys. Acta 1360 (1997) 3-16
9. Scheinberg I.H., and Sternlieb I. Wilson disease and idiopathic copper toxicosis. Am. J. Clin. Nutr. 63 (1996) 842S-845S
10. Cheah D.M., Deal Y.J., Wright P.F., Buck N.E., Chow C.W., Mercer J.F., and Allen K.J. Heterozygous tx mice have an increased sensitivity to copper loading: implications for Wilson's disease carriers. BioMetals 20 (2007) 751-757
11. Pankit A.N., and Bhave S.A. Copper metabolic defects and liver disease: environmental aspects. J. Gastroenterol. Hepatol. 17 (2002) S403-S407
12. Pandit A., and Bhave S. Present interpretation of the role of copper in Indian childhood cirrhosis. Am. J. Clin. Nutr. 63 (1996) 830S-835S
13. Committee on Copper in Drinking Water, Board on Environmental Studies and Toxicology, Commission on Life Sciences, and National Research Council. Copper in Drinking Water (2000), National Academy Press, Washington, DC
14. Agency for Toxic Substances and Disease Registry. In: US Public Health Service (Ed). Toxicological Profile for Copper. TP-90-08 edit (2004), US Public Health Service, Atlanta
15. Zhu Z., and Thiele D.J. Toxic metal-responsive gene transcription. EXS 77 (1996) 307-320
16. Song M.O., Li J., and Freedman J.H. Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol. Genomics 38 (2009) 386-401
17. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18 (2000) 621-663
18. Hayden M.S., and Ghosh S. Signaling to NF-κB. Genes Dev. 18 (2004) 2195-2224
19. Chen F., Ding M., Castranova V., and Shi X. Carcinogenic metals and NF-κB activation. Mol. Cell. Biochem. 222 (2001) 159-171
20. Cisternas F.A., Tapia G., Arredondo M., Cartier-Ugarte D., Romanque P., Sierralta W.D., et al. Early histological and functional effects of chronic copper exposure in rat liver. BioMetals 18 (2005) 541-551
21. Persichini T., Percario Z., Mazzon E., Colasanti M., Cuzzocrea S., and Musci G. Copper activates the NF-κB pathway in vivo. Antioxid. Redox Signal. 8 (2006) 1897-1904
22. Muller P., van Bakel H., van de Sluis B., Holstege F., Wijmenga C., and Klomp L.W. Gene expression profiling of liver cells after copper overload in vivo and in vitro reveals new copper-regulated genes. J. Biol. Inorg. Chem. 12 (2007) 495-507
23. Satake H., Suzuki K., Aoki T., Otsuka M., Sugiura Y., Yamamoto T., and Inoue J. Cupric ion blocks NF-κB activation through inhibiting the signal-induced phosphorylation of I κBa. Biochem. Biophys. Res. Commun. 216 (1995) 568-573
24. Zhai Q., Ji H., Zheng Z., Yu X., Sun L., and Liu X. Copper induces apoptosis in BA/F3beta cells: Bax, reactive oxygen species, and NF-κB are involved. J. Cell. Physiol. 184 (2000) 161-170
25. Lewis J.B., Randol T.M., Lockwood P.E., and Wataha J.C. Effect of subtoxic concentrations of metal ions on NF-κB activation in THP-1 human monocytes. J. Biomed. Mater. Res. A 64 (2003) 217-224
26. Lewis J.B., Wataha J.C., Randol T.M., McCloud V.V., and Lockwood P.E. Metal ions alter lipopolysaccharide-induced NF-κB binding in monocytes. J. Biomed. Mater. Res. A 67 (2003) 868-875
27. Jimenez Del Rio M., and Velez-Pardo C. Transition metal-induced apoptosis in lymphocytes via hydroxyl radical generation, mitochondria dysfunction, and caspase-3 activation: an in vitro model for neurodegeneration. Arch. Med. Res. 35 (2004) 185-193
28. Ho Sui S.J., Mortimer J.R., Arenillas D.J., Brumm J., Walsh C.J., Kennedy B.P., and Wasserman W.W. oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes. Nucleic Acids Res. 33 (2005) 3154-3164
29. 2)-induced NF-κB DNA binding activity and DNA damage in HepG2 cells. Carcinogenesis 19 (1998) 1583-1589
30. Coronado V., Nanji M., and Cox D.W. The Jackson toxic milk mouse as a model for copper loading. Mamm. Genome 12 (2001) 793-795
31. Roberts E.A., Lau C.H., da Silveira T.R., and Yang S. Developmental expression of Commd1 in the liver of the Jackson toxic milk mouse. Biochem. Biophys. Res. Commun. 363 (2007) 921-925
32. Armendariz A.D., Gonzalez M., Loguinov A.V., and Vulpe C.D. Gene expression profiling in chronic copper overload reveals upregulation of Prnp and App. Physiol. Genomics 20 (2004) 45-54
33. Klein D., Lichtmannegger J., Finckh M., and Summer K.H. Gene expression in the liver of Long-Evans cinnamon rats during the development of hepatitis. Arch. Toxicol. 77 (2003) 568-575
34. Luedde T., and Trautwein C. Intracellular survival pathways in the liver. Liver Int. 26 (2006) 1163-1174
35. Schoemaker M.H., and Moshage H. Defying death: the hepatocyte's survival kit. Clin. Sci. 107 (2004) 13-25
36. Jeong W., Park S.J., Chang T.S., Lee D.Y., and Rhee S.G. Molecular mechanism of the reduction of cysteine sulfinic acid of peroxiredoxin to cysteine by mammalian sulfiredoxin. J. Biol. Chem. 281 (2006) 14400-14407
37. Maeda S., and Omata M. Inflammation and cancer: role of nuclear factor-κB activation. Cancer Sci. 99 (2008) 836-842
38. Tai D.I., Tsai S.L., Chen Y.M., Chuang Y.L., Peng C.Y., Sheen I.S., et al. Activation of nuclear factor κB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 31 (2000) 656-664
39. Ebara M., Fukuda H., Hatano R., Yoshikawa M., Sugiura N., Saisho H., et al. Metal contents in the liver of patients with chronic liver disease caused by hepatitis C virus. Reference to hepatocellular carcinoma. Oncology 65 (2003) 323-330
40. Freedman J.H., Weiner R.J., and Peisach J. Resistance to copper toxicity of cultured hepatoma cells. Characterization of resistant cell lines. J. Biol. Chem. 261 (1986) 11840-11848
41. Song M.O., and Freedman J.H. Expression of copper-responsive genes in HepG2 cells. Mol. Cell. Biochem. 279 (2005) 141-147
42. Onai Y., Suzuki J., Kakuta T., Maejima Y., Haraguchi G., Fukasawa H., et al. Inhibition of IκB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury. Cardiovasc. Res. 63 (2004) 51-59
43. Chiao P.J., Na R., Niu J., Sclabas G.M., Dong Q., and Curley S.A. Role of Rel/NF-κB transcription factors in apoptosis of human hepatocellular carcinoma cells. Cancer 95 (2002) 1696-1705
44. Rozen S., and Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132 (2000) 365-386
45. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- ΔΔC(T)) method. Methods 25 (2001) 402-408
46. Vadigepalli R., Chakravarthula P., Zak D.E., Schwaber J.S., and Gonye G.E. PAINT: a promoter analysis and interaction network generation tool for gene regulatory network identification. Omics 7 (2003) 235-252
47. Matys V., Kel-Margoulis O.V., Fricke E., Liebich I., Land S., Barre-Dirrie A., et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 34 (2006) D108-D110